List of Tables
Table 1. Global ImmunOthersapy Drugs for Multiple Myeloma Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of INF-α
Table 3. Key Players of IL-6
Table 4. Key Players of Rituximab
Table 5. Key Players of Others
Table 6. Global ImmunOthersapy Drugs for Multiple Myeloma Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global ImmunOthersapy Drugs for Multiple Myeloma Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global ImmunOthersapy Drugs for Multiple Myeloma Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global ImmunOthersapy Drugs for Multiple Myeloma Market Share by Region (2019-2024)
Table 10. Global ImmunOthersapy Drugs for Multiple Myeloma Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global ImmunOthersapy Drugs for Multiple Myeloma Market Share by Region (2025-2030)
Table 12. ImmunOthersapy Drugs for Multiple Myeloma Market Trends
Table 13. ImmunOthersapy Drugs for Multiple Myeloma Market Drivers
Table 14. ImmunOthersapy Drugs for Multiple Myeloma Market Challenges
Table 15. ImmunOthersapy Drugs for Multiple Myeloma Market Restraints
Table 16. Global ImmunOthersapy Drugs for Multiple Myeloma Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global ImmunOthersapy Drugs for Multiple Myeloma Market Share by Players (2019-2024)
Table 18. Global Top ImmunOthersapy Drugs for Multiple Myeloma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ImmunOthersapy Drugs for Multiple Myeloma as of 2023)
Table 19. Ranking of Global Top ImmunOthersapy Drugs for Multiple Myeloma Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by ImmunOthersapy Drugs for Multiple Myeloma Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players ImmunOthersapy Drugs for Multiple Myeloma Product Solution and Service
Table 23. Date of Enter into ImmunOthersapy Drugs for Multiple Myeloma Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global ImmunOthersapy Drugs for Multiple Myeloma Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global ImmunOthersapy Drugs for Multiple Myeloma Revenue Market Share by Type (2019-2024)
Table 27. Global ImmunOthersapy Drugs for Multiple Myeloma Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global ImmunOthersapy Drugs for Multiple Myeloma Revenue Market Share by Type (2025-2030)
Table 29. Global ImmunOthersapy Drugs for Multiple Myeloma Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global ImmunOthersapy Drugs for Multiple Myeloma Revenue Market Share by Application (2019-2024)
Table 31. Global ImmunOthersapy Drugs for Multiple Myeloma Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global ImmunOthersapy Drugs for Multiple Myeloma Revenue Market Share by Application (2025-2030)
Table 33. North America ImmunOthersapy Drugs for Multiple Myeloma Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America ImmunOthersapy Drugs for Multiple Myeloma Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America ImmunOthersapy Drugs for Multiple Myeloma Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe ImmunOthersapy Drugs for Multiple Myeloma Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe ImmunOthersapy Drugs for Multiple Myeloma Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe ImmunOthersapy Drugs for Multiple Myeloma Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific ImmunOthersapy Drugs for Multiple Myeloma Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific ImmunOthersapy Drugs for Multiple Myeloma Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific ImmunOthersapy Drugs for Multiple Myeloma Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America ImmunOthersapy Drugs for Multiple Myeloma Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America ImmunOthersapy Drugs for Multiple Myeloma Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America ImmunOthersapy Drugs for Multiple Myeloma Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa ImmunOthersapy Drugs for Multiple Myeloma Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa ImmunOthersapy Drugs for Multiple Myeloma Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa ImmunOthersapy Drugs for Multiple Myeloma Market Size by Country (2025-2030) & (US$ Million)
Table 48. Tonghua Dongbao Pharmaceutical Company Detail
Table 49. Tonghua Dongbao Pharmaceutical Business Overview
Table 50. Tonghua Dongbao Pharmaceutical ImmunOthersapy Drugs for Multiple Myeloma Product
Table 51. Tonghua Dongbao Pharmaceutical Revenue in ImmunOthersapy Drugs for Multiple Myeloma Business (2019-2024) & (US$ Million)
Table 52. Tonghua Dongbao Pharmaceutical Recent Development
Table 53. Sumitomo Company Detail
Table 54. Sumitomo Business Overview
Table 55. Sumitomo ImmunOthersapy Drugs for Multiple Myeloma Product
Table 56. Sumitomo Revenue in ImmunOthersapy Drugs for Multiple Myeloma Business (2019-2024) & (US$ Million)
Table 57. Sumitomo Recent Development
Table 58. Merck Company Detail
Table 59. Merck Business Overview
Table 60. Merck ImmunOthersapy Drugs for Multiple Myeloma Product
Table 61. Merck Revenue in ImmunOthersapy Drugs for Multiple Myeloma Business (2019-2024) & (US$ Million)
Table 62. Merck Recent Development
Table 63. Biogen Company Detail
Table 64. Biogen Business Overview
Table 65. Biogen ImmunOthersapy Drugs for Multiple Myeloma Product
Table 66. Biogen Revenue in ImmunOthersapy Drugs for Multiple Myeloma Business (2019-2024) & (US$ Million)
Table 67. Biogen Recent Development
Table 68. Schering-Plough Company Detail
Table 69. Schering-Plough Business Overview
Table 70. Schering-Plough ImmunOthersapy Drugs for Multiple Myeloma Product
Table 71. Schering-Plough Revenue in ImmunOthersapy Drugs for Multiple Myeloma Business (2019-2024) & (US$ Million)
Table 72. Schering-Plough Recent Development
Table 73. Roche Company Detail
Table 74. Roche Business Overview
Table 75. Roche ImmunOthersapy Drugs for Multiple Myeloma Product
Table 76. Roche Revenue in ImmunOthersapy Drugs for Multiple Myeloma Business (2019-2024) & (US$ Million)
Table 77. Roche Recent Development
Table 78. Glaxo Company Detail
Table 79. Glaxo Business Overview
Table 80. Glaxo ImmunOthersapy Drugs for Multiple Myeloma Product
Table 81. Glaxo Revenue in ImmunOthersapy Drugs for Multiple Myeloma Business (2019-2024) & (US$ Million)
Table 82. Glaxo Recent Development
Table 83. Chiron Company Detail
Table 84. Chiron Business Overview
Table 85. Chiron ImmunOthersapy Drugs for Multiple Myeloma Product
Table 86. Chiron Revenue in ImmunOthersapy Drugs for Multiple Myeloma Business (2019-2024) & (US$ Million)
Table 87. Chiron Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ImmunOthersapy Drugs for Multiple Myeloma Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global ImmunOthersapy Drugs for Multiple Myeloma Market Share by Type: 2023 VS 2030
Figure 3. INF-α Features
Figure 4. IL-6 Features
Figure 5. Rituximab Features
Figure 6. Others Features
Figure 7. Global ImmunOthersapy Drugs for Multiple Myeloma Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global ImmunOthersapy Drugs for Multiple Myeloma Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Drug Center Case Studies
Figure 11. Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. ImmunOthersapy Drugs for Multiple Myeloma Report Years Considered
Figure 14. Global ImmunOthersapy Drugs for Multiple Myeloma Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global ImmunOthersapy Drugs for Multiple Myeloma Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global ImmunOthersapy Drugs for Multiple Myeloma Market Share by Region: 2023 VS 2030
Figure 17. Global ImmunOthersapy Drugs for Multiple Myeloma Market Share by Players in 2023
Figure 18. Global Top ImmunOthersapy Drugs for Multiple Myeloma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ImmunOthersapy Drugs for Multiple Myeloma as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by ImmunOthersapy Drugs for Multiple Myeloma Revenue in 2023
Figure 20. North America ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America ImmunOthersapy Drugs for Multiple Myeloma Market Share by Country (2019-2030)
Figure 22. United States ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe ImmunOthersapy Drugs for Multiple Myeloma Market Share by Country (2019-2030)
Figure 26. Germany ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific ImmunOthersapy Drugs for Multiple Myeloma Market Share by Region (2019-2030)
Figure 34. China ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America ImmunOthersapy Drugs for Multiple Myeloma Market Share by Country (2019-2030)
Figure 42. Mexico ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa ImmunOthersapy Drugs for Multiple Myeloma Market Share by Country (2019-2030)
Figure 46. Turkey ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia ImmunOthersapy Drugs for Multiple Myeloma Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Tonghua Dongbao Pharmaceutical Revenue Growth Rate in ImmunOthersapy Drugs for Multiple Myeloma Business (2019-2024)
Figure 49. Sumitomo Revenue Growth Rate in ImmunOthersapy Drugs for Multiple Myeloma Business (2019-2024)
Figure 50. Merck Revenue Growth Rate in ImmunOthersapy Drugs for Multiple Myeloma Business (2019-2024)
Figure 51. Biogen Revenue Growth Rate in ImmunOthersapy Drugs for Multiple Myeloma Business (2019-2024)
Figure 52. Schering-Plough Revenue Growth Rate in ImmunOthersapy Drugs for Multiple Myeloma Business (2019-2024)
Figure 53. Roche Revenue Growth Rate in ImmunOthersapy Drugs for Multiple Myeloma Business (2019-2024)
Figure 54. Glaxo Revenue Growth Rate in ImmunOthersapy Drugs for Multiple Myeloma Business (2019-2024)
Figure 55. Chiron Revenue Growth Rate in ImmunOthersapy Drugs for Multiple Myeloma Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed